124 related articles for article (PubMed ID: 36861834)
1. Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.
Lane-Reticker SK; Kessler EA; Muscato AJ; Kim SY; Doench JG; Yates KB; Manguso RT; Dubrot J
STAR Protoc; 2023 Mar; 4(1):102082. PubMed ID: 36861834
[TBL] [Abstract][Full Text] [Related]
2. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
Uranga M; Aragonés V; Daròs JA; Pasin F
STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
[TBL] [Abstract][Full Text] [Related]
3. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
Hundley FV; Toczyski DP
STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
[TBL] [Abstract][Full Text] [Related]
4. Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cells.
Laprie-Sentenac M; Cretet-Rodeschini C; Menger L
STAR Protoc; 2023 Mar; 4(1):101922. PubMed ID: 36516053
[TBL] [Abstract][Full Text] [Related]
5. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
Ryø LB; Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
[TBL] [Abstract][Full Text] [Related]
6. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
Qiu Y; Ding Q
STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
[TBL] [Abstract][Full Text] [Related]
7. Protocol for arrayed gRNA screening by base editors in mammalian cell lines using lentiviral system.
Ravi NS; George A; Mohankumar KM
STAR Protoc; 2023 Dec; 4(4):102668. PubMed ID: 37922314
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
[TBL] [Abstract][Full Text] [Related]
9. piggyBac mediates efficient in vivo CRISPR library screening for tumorigenesis in mice.
Xu C; Qi X; Du X; Zou H; Gao F; Feng T; Lu H; Li S; An X; Zhang L; Wu Y; Liu Y; Li N; Capecchi MR; Wu S
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):722-727. PubMed ID: 28062688
[TBL] [Abstract][Full Text] [Related]
10. Protocol for generating mutant zebrafish using CRISPR-Cas9 followed by quantitative evaluation of vascular formation.
Luo J; Lu C; Wang M; Yang X
STAR Protoc; 2023 Dec; 4(4):102753. PubMed ID: 38041822
[TBL] [Abstract][Full Text] [Related]
11. Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library.
Olivieri M; Durocher D
STAR Protoc; 2021 Mar; 2(1):100321. PubMed ID: 33598657
[TBL] [Abstract][Full Text] [Related]
12. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
[TBL] [Abstract][Full Text] [Related]
13. Generation of
Pelletier S; Tummers B; Green DR
STAR Protoc; 2020 Dec; 1(3):100181. PubMed ID: 33377075
[TBL] [Abstract][Full Text] [Related]
14. Protocols for transgenesis at a safe harbor site in the Xenopus laevis genome using CRISPR-Cas9.
Shibata Y; Okumura A; Mochii M; Suzuki KT
STAR Protoc; 2023 Sep; 4(3):102382. PubMed ID: 37389994
[TBL] [Abstract][Full Text] [Related]
15. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
Wang X; Xu BL; Chen XW
STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
[TBL] [Abstract][Full Text] [Related]
16. Protocol of CRISPR-Cas9 knockout screens for identifying ferroptosis regulators.
Yang X; Duan S; Li Z; Wang Z; Kon N; Zhang Z; Gu W
STAR Protoc; 2023 Dec; 4(4):102762. PubMed ID: 38048220
[TBL] [Abstract][Full Text] [Related]
17. Optimized protocols for efficient gene editing in mouse hepatocytes
Chen Y; Ding Q
STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
[TBL] [Abstract][Full Text] [Related]
18. Extensible combinatorial CRISPR screening in mammalian cells.
Zhou P; Wan YK; Chan BKC; Choi GCG; Wong ASL
STAR Protoc; 2021 Mar; 2(1):100255. PubMed ID: 33490975
[TBL] [Abstract][Full Text] [Related]
19. Computational pipeline for designing guide RNAs for mismatch-CRISPRi.
van Gestel J; Hawkins JS; Todor H; Gross CA
STAR Protoc; 2021 Jun; 2(2):100521. PubMed ID: 34027480
[TBL] [Abstract][Full Text] [Related]
20. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
Gao P; Dong X; Wang Y; Wei GH
STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
